Ad is loading...
MENU

KTTA Pasithea Therapeutics Corp Forecast, Technical & Fundamental Analysis

Industry Biotechnology
KTTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
KTTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KTTA is expected to report earnings to -17 cents per share on August 30

Pasithea Therapeutics Corp KTTA Stock Earnings Reports
Q2'23
Est.
$-0.17
Q1'23
Est.
$-0.17
Q4'22
Est.
$-0.18
Q3'22
Missed
by $0.03
Q2'22
Est.
$-0.11
The last earnings report on May 31 showed earnings per share of -17 cents, meeting the estimate of -17 cents. With 45.97K shares outstanding, the current market capitalization sits at 4.03M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1111 Lincoln Road
Phone
+1 702 514-4174
Employees
8
Web
https://www.pasithea.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBT13.760.61
+4.64%
Permian Basin Royalty Trust
FTK8.060.21
+2.68%
Flotek Industries
FBIN75.760.86
+1.15%
Fortune Brands Innovations
SMX0.26N/A
-0.43%
SMX (Security Matters) Public Limited
ZETA21.72-1.39
-6.01%
Zeta Global Holdings Corp

KTTA and Stocks

Correlation & Price change

A.I.dvisor tells us that KTTA and FATE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
+1.27%
FATE - KTTA
32%
Poorly correlated
+1.83%
ACET - KTTA
25%
Poorly correlated
-6.11%
SPRB - KTTA
24%
Poorly correlated
+0.89%
RVNC - KTTA
24%
Poorly correlated
+1.06%
TRAW - KTTA
24%
Poorly correlated
-4.47%
More